Dr. Dalvir Gill, PhD


Chief Executive Officer

TransCelerate BioPharma, Inc.

Dr. Dalvir Gill has more than 25 years of drug development experience. Prior to his appointment as CEO of TransCelerate Biopharma, he was the President of a Phase II-IV Drug Development at Inventive Health Clinical, an international CRO.